Skip to main content
Top
Published in: Rheumatology International 12/2007

01-10-2007 | Original Article

Serum oxidative–antioxidative status in patients with ankylosing spondilitis

Authors: Mehmet Karakoc, Ozlem Altindag, Huseyin Keles, Neslihan Soran, Sahabettin Selek

Published in: Rheumatology International | Issue 12/2007

Login to get access

Abstract

Ankylosing spondylitis (AS) is an inflammatory disorder with unknown etiology that mainly affects the axial skeleton as well as the peripheral joints and extra-articular structures. The aim of this study was to evaluate the total antioxidant status (TAS), total oxidative status (TOS) and oxidative stress index (OSI) in patients with ankylosing spondylitis (AS). Fifty AS patients with a mean Bath AS Activity Index (BASDAI) 4.6 (range 4–9.3) and 26 healthy controls were included in the study. Plasma TAS, TOS levels were determined by using novel automated methods. The OSI was calculated. Plasma TOS level and OSI values were significantly higher, and plasma TAS level was lower in patients than in healthy controls (15.8 ± 4. 9 vs. 4.3 ± 2.8, 12.8 ± 3. 9 vs. 9.6 ± 5.5, 1.2 ± 0.03 vs. 1.8 ± 0.2, respectively, P < 0.001 for all). There was no significant correlation between oxidant/antioxidant parameters and disease activity. The results of this study indicated that increased oxidant and decreased antioxidant capacity may be associated with the pathogenesis of AS.
Literature
1.
go back to reference Ho KJ, Chen PQ, Chang CY, Lu FJ (2000) The oxidative metabolism of circulating phagocytes in ankylosing spondylitis: determination by whole blood chemiluminescence. Ann Rheum Dis 59:338–341PubMedCrossRef Ho KJ, Chen PQ, Chang CY, Lu FJ (2000) The oxidative metabolism of circulating phagocytes in ankylosing spondylitis: determination by whole blood chemiluminescence. Ann Rheum Dis 59:338–341PubMedCrossRef
2.
go back to reference Ozgocmen S, Sogut S, Ardicoglu O, Fadillioglu E, Pekkutucu I, Akyol O (2004) Serum nitric oxide, catalase, superoxide dismutase, and malondialdehyde status in patients with ankylosing spondylitis. Rheumatol Int 24:80–83PubMedCrossRef Ozgocmen S, Sogut S, Ardicoglu O, Fadillioglu E, Pekkutucu I, Akyol O (2004) Serum nitric oxide, catalase, superoxide dismutase, and malondialdehyde status in patients with ankylosing spondylitis. Rheumatol Int 24:80–83PubMedCrossRef
3.
go back to reference Karakucuk S, Baskol G, Oner AO, Baskol M, Mirza E, Ustdal M (2004) Serum paraoxonase activity is decreased in the active stage of Behcet’s disease. Br J Ophthalmol 88:1256–1258PubMedCrossRef Karakucuk S, Baskol G, Oner AO, Baskol M, Mirza E, Ustdal M (2004) Serum paraoxonase activity is decreased in the active stage of Behcet’s disease. Br J Ophthalmol 88:1256–1258PubMedCrossRef
4.
go back to reference Sarban S, Kocyigit A, Yazar M, Isikan UE (2005) Plasma total antioxidant capacity, lipid peroxidation, and erythrocyte antioxidant enzyme activities in patients with rheumatoid arthritis and osteoarthritis. Clin Biochem 38:981–986PubMedCrossRef Sarban S, Kocyigit A, Yazar M, Isikan UE (2005) Plasma total antioxidant capacity, lipid peroxidation, and erythrocyte antioxidant enzyme activities in patients with rheumatoid arthritis and osteoarthritis. Clin Biochem 38:981–986PubMedCrossRef
5.
go back to reference Harma M, Harma M, Erel O (2003) Increased oxidative stress in patients with hydatidiform mole. Swiss Med Wkly 133:563–536PubMed Harma M, Harma M, Erel O (2003) Increased oxidative stress in patients with hydatidiform mole. Swiss Med Wkly 133:563–536PubMed
6.
go back to reference Tak PP, Zvaifler NJ, Green DR, Firestein GS (2000) Rheumatoid arthritis and p53: how oxidative stress might alter the course of inflammatory diseases. Immunol Today 21:78–82PubMedCrossRef Tak PP, Zvaifler NJ, Green DR, Firestein GS (2000) Rheumatoid arthritis and p53: how oxidative stress might alter the course of inflammatory diseases. Immunol Today 21:78–82PubMedCrossRef
7.
go back to reference Lunec J, Halloran SP, White AG, Dormandy TL (1981) Free-radical oxidation (peroxidation) products in serum and synovial fluid in rheumatoid arthritis. J Rheumatol 8:233–245PubMed Lunec J, Halloran SP, White AG, Dormandy TL (1981) Free-radical oxidation (peroxidation) products in serum and synovial fluid in rheumatoid arthritis. J Rheumatol 8:233–245PubMed
8.
go back to reference Blake DR, Merry P, Unsworth J, Ballard R, Morris CJ, Gray L, Lunec J (1989) Hypoxic-reperfusion injury in the inflamed human joint. Lancet 11:289–293CrossRef Blake DR, Merry P, Unsworth J, Ballard R, Morris CJ, Gray L, Lunec J (1989) Hypoxic-reperfusion injury in the inflamed human joint. Lancet 11:289–293CrossRef
9.
go back to reference Biasi D, Carletto A, Caramaschi P, Caramaschi P, Zeminian S, Bambara LM (1995) Neutrophil functions, spondylarthropathies and HLA-B27: a study of 43 patients. Clin Exp Rheumatol 13:623–627PubMed Biasi D, Carletto A, Caramaschi P, Caramaschi P, Zeminian S, Bambara LM (1995) Neutrophil functions, spondylarthropathies and HLA-B27: a study of 43 patients. Clin Exp Rheumatol 13:623–627PubMed
10.
go back to reference Calin A, Nakache JP, Gueguen A, Zeidler H, Mielants H, Dougados M (1999) Defining disease activity in ankylosing spondylitis: is a combination of variables (Bath Ankylosing Spondylitis Disease Activity Index) an appropriate instrument? Rheumatology (Oxford) 38:878–882CrossRef Calin A, Nakache JP, Gueguen A, Zeidler H, Mielants H, Dougados M (1999) Defining disease activity in ankylosing spondylitis: is a combination of variables (Bath Ankylosing Spondylitis Disease Activity Index) an appropriate instrument? Rheumatology (Oxford) 38:878–882CrossRef
11.
go back to reference Erel O (2004) A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation. Clin Biochem 37:277–285PubMedCrossRef Erel O (2004) A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation. Clin Biochem 37:277–285PubMedCrossRef
12.
go back to reference Erel O (2005) A new automated colorimetric method for measuring total oxidant status. Clin Biochem 38:1103–1111PubMedCrossRef Erel O (2005) A new automated colorimetric method for measuring total oxidant status. Clin Biochem 38:1103–1111PubMedCrossRef
13.
go back to reference Wendling D, Didier JM, Vuitton DA (1991) The phagocyte oxidative metabolism function in ankylosing spondylitis. Rheumatol Int 11:187–189PubMedCrossRef Wendling D, Didier JM, Vuitton DA (1991) The phagocyte oxidative metabolism function in ankylosing spondylitis. Rheumatol Int 11:187–189PubMedCrossRef
14.
go back to reference Henrotin YE, Bruckner P, Pujol JP (2003) The role of reactive oxygen species in homeostasis and degradation of cartilage. Osteoarthr Cartil 11:747–755PubMedCrossRef Henrotin YE, Bruckner P, Pujol JP (2003) The role of reactive oxygen species in homeostasis and degradation of cartilage. Osteoarthr Cartil 11:747–755PubMedCrossRef
15.
go back to reference Hitchon CA, El-Gabalawy HS (2004) Oxidation in rheumatoid arthritis. Arthr Res Ther 6:265–278CrossRef Hitchon CA, El-Gabalawy HS (2004) Oxidation in rheumatoid arthritis. Arthr Res Ther 6:265–278CrossRef
16.
go back to reference Yazici C, Kose K, Calis M, Kuzuguden S, Kirnap M (2004) Protein oxidation status in patients with ankylosing spondylitis. Rheumatology (Oxford) 43:1235–1259CrossRef Yazici C, Kose K, Calis M, Kuzuguden S, Kirnap M (2004) Protein oxidation status in patients with ankylosing spondylitis. Rheumatology (Oxford) 43:1235–1259CrossRef
17.
go back to reference Mungan AG, Can M, Acikgoz S, Esturk E, Altinyazar C (2006) Lipid peroxidation and homocysteine levels in Behcet’s disease. Clin Chem Lab Med 44:1115–1118PubMedCrossRef Mungan AG, Can M, Acikgoz S, Esturk E, Altinyazar C (2006) Lipid peroxidation and homocysteine levels in Behcet’s disease. Clin Chem Lab Med 44:1115–1118PubMedCrossRef
18.
go back to reference Tutuncu ZN, Bilgie A, Kennedy LG, Calin A (1994) Interleukin-6, acute phase reactants and clinical status in ankylosing spondylitis. Ann Rheum Dis 53:425–426PubMedCrossRef Tutuncu ZN, Bilgie A, Kennedy LG, Calin A (1994) Interleukin-6, acute phase reactants and clinical status in ankylosing spondylitis. Ann Rheum Dis 53:425–426PubMedCrossRef
19.
go back to reference Stichtenoth DO, Wollenhaupt J, Andersone D, Zeidler H, Frolich JC (1995) Elevated serum nitrate concentrations in active spondyloarthropathies. Br J Rheumatol 34:616–619PubMedCrossRef Stichtenoth DO, Wollenhaupt J, Andersone D, Zeidler H, Frolich JC (1995) Elevated serum nitrate concentrations in active spondyloarthropathies. Br J Rheumatol 34:616–619PubMedCrossRef
20.
go back to reference Griffiths HR (2005) ROS as signalling molecules in T cells-evidence for abnormal redox signalling in the autoimmune disease, rheumatoid arthritis. Redox Rep 10:273–280PubMedCrossRef Griffiths HR (2005) ROS as signalling molecules in T cells-evidence for abnormal redox signalling in the autoimmune disease, rheumatoid arthritis. Redox Rep 10:273–280PubMedCrossRef
21.
go back to reference Pham TN, Rahman P, Tobin YM, Khraishi MM, Hamilton SF, Alderdice C, Richardson VJ (2003) Elevated serum nitric oxide levels in patients with inflammatory arthritis associated with co-expression of inducible nitric oxide synthase and protein kinase C-eta in peripheral blood monocyte-derived macrophages. J Rheumatol 30:2529–2534PubMed Pham TN, Rahman P, Tobin YM, Khraishi MM, Hamilton SF, Alderdice C, Richardson VJ (2003) Elevated serum nitric oxide levels in patients with inflammatory arthritis associated with co-expression of inducible nitric oxide synthase and protein kinase C-eta in peripheral blood monocyte-derived macrophages. J Rheumatol 30:2529–2534PubMed
Metadata
Title
Serum oxidative–antioxidative status in patients with ankylosing spondilitis
Authors
Mehmet Karakoc
Ozlem Altindag
Huseyin Keles
Neslihan Soran
Sahabettin Selek
Publication date
01-10-2007
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 12/2007
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-007-0352-3

Other articles of this Issue 12/2007

Rheumatology International 12/2007 Go to the issue